Augmentin '125' and Gaviscon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Augmentin '125' (amoxicillin; clavulanate potassium) and Gaviscon (aluminum hydroxide; magnesium trisilicate). Common drug interactions include alanine aminotransferase increased among females and lower respiratory tract infection among males.

The phase IV clinical study analyzes what interactions people have when they take Augmentin '125' and Gaviscon. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Augmentin '125'?

Augmentin '125' has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 10,452 Augmentin '125' users. Check the latest studies of Augmentin '125'.

What is Gaviscon?

Gaviscon has active ingredients of aluminum hydroxide; magnesium trisilicate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 12,355 Gaviscon users. Check the latest studies of Gaviscon.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 21, 2026

41 people who take Augmentin '125' and Gaviscon together, and have interactions are studied.

Augmentin '125' and Gaviscon drug interactions.

What are the common drug interactions of Augmentin '125' and Gaviscon, by gender? *:

female:

  1. Alanine aminotransferase increased
  2. Antinuclear antibody positive
  3. Arterial haemorrhage
  4. Arthralgia (joint pain)
  5. Aspartate aminotransferase increased
  6. Asthenia (weakness)
  7. Back pain
  8. Bacterial sepsis
  9. Beta 2 microglobulin increased
  10. Blood creatine increased

male:

  1. Lower respiratory tract infection
  2. Wheezing (a high-pitched whistling sound made while you breath)
  3. Multiple myeloma (cancer of the plasma cells)
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Pancreatitis (inflammation of pancreas)
  6. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  7. Somnolence (a state of near-sleep, a strong desire for sleep)
  8. Abdominal wall haematoma (abdominal wall blood clotting)
  9. Abnormal behaviour
  10. Activities of daily living impaired

What are the common drug interactions of Augmentin '125' and Gaviscon, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cholecystitis acute (rapid infection of gallbladder)
  2. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)

40-49:

  1. Anaemia (lack of blood)
  2. Antinuclear antibody positive
  3. Aspartate aminotransferase increased
  4. Bacterial sepsis
  5. Colon cancer
  6. Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)
  7. General physical health deterioration (weak health status)
  8. Headache (pain in head)
  9. Lactic acidosis (low ph in body tissues)
  10. Livedo reticularis (a lace-like purplish discoloration of the skin)

50-59:

n/a

60+:

  1. Pyrexia (fever)
  2. General physical health deterioration (weak health status)
  3. Diarrhoea
  4. Erythema (redness of the skin)
  5. International normalised ratio increased
  6. Intestinal perforation (complete penetration of the wall of the intestine)
  7. Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  8. Multi-organ failure (multisystem organ failure)
  9. Multiple myeloma (cancer of the plasma cells)
  10. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

What are the existing conditions these people have? *

  1. Pain: 6 people, 14.63%
  2. Multiple Myeloma (cancer of the plasma cells): 5 people, 12.20%
  3. Diarrhea: 5 people, 12.20%
  4. Insomnia (sleeplessness): 4 people, 9.76%
  5. High Blood Pressure: 4 people, 9.76%
  6. Stress And Anxiety: 3 people, 7.32%
  7. Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 3 people, 7.32%
  8. High Blood Cholesterol: 3 people, 7.32%
  9. Erysipelas (bacterial skin infection): 3 people, 7.32%
  10. Constipation: 3 people, 7.32%

* Approximation only. Some reports may have incomplete information.

Do you take Augmentin '125' and Gaviscon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Augmentin '125' and Gaviscon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Augmentin '125':

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Gaviscon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Augmentin '125' and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gaviscon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amoxicillin; clavulanate potassium and aluminum hydroxide; magnesium trisilicate (the active ingredients of Augmentin '125' and Gaviscon, respectively), and Augmentin '125' and Gaviscon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: